Infosys Share Price Surges Over 2%; Truist Strengthens Strategic Collaboration

Infosys has expanded its work with Truist as the US bank builds up its technology and operations centre in Hyderabad. The companies announced the development on October 19, 2026, as per the exchange filing.
More Than 1,000 Employees to Join
As part of the expanded partnership, more than 1,000 employees are expected to be onboarded later this month. Truist is bringing together work currently handled by multiple service providers in India under a more integrated operating model.
The Hyderabad centre will bring technology, data, AI and operations teams closer together. Truist expects the setup to help it reduce reliance on outside vendors and make collaboration across its global teams easier.
Focus on AI and Banking Technology
Infosys will use its financial services experience and its AI platform, Infosys Topaz, to support the centre's development.
The plan is to build a centre of excellence that can eventually operate independently, while helping Truist expand its digital capabilities and improve customer experience.
Truist, headquartered in Charlotte, North Carolina, had total assets of $556 billion as of June 30, 2026. The bank said the Hyderabad centre is part of its longer-term investment in AI-enabled operations and technology.
Read More: RailTel Corporation Share Price in Focus After Winning ₹47.4 Crore Haryana LAN Contract!
Infosys Share Price Performance
As of October 21, 2026, at 11:44 AM, Infosys share price was trading at ₹1,156.20 per share, reflecting a 2.26% change from the previous trading session.
Conclusion
The expanded partnership gives Infosys a larger role in Truist's India operations as the bank brings more work under one setup in Hyderabad. More than 1,000 employees are expected to join the centre this month, with AI, technology and banking operations at the heart of the collaboration.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Oct 21, 2026, 12:14 PM IST

Team Angel One
- Dr Reddy’s Laboratories Share Price in Focus; Gets Approval for Zytorvi in Advanced Esophageal Cancer
- Hexaware Technologies Share Price in Focus; Board Declares ₹9.50 Dividend Per Share
- Transrail Lighting Share Price in Focus After Winning ₹927 Crore Orders
- UltraTech Cement Share Price Surges Over 2%; Reports 21.3% Rise in Q2FY27 Net Profit
- Tatva Chintan Share Price Surges 7% as Q2FY27 Net Profit Rises 116% to ₹21.5 Crore




